297 related articles for article (PubMed ID: 29752025)
1. Correlates of HPV vaccine initiation and provider recommendation among male adolescents, 2014 NIS-Teen.
Landis K; Bednarczyk RA; Gaydos LM
Vaccine; 2018 Jun; 36(24):3498-3504. PubMed ID: 29752025
[TBL] [Abstract][Full Text] [Related]
2. Health care provider recommendation, human papillomavirus vaccination, and race/ethnicity in the US National Immunization Survey.
Ylitalo KR; Lee H; Mehta NK
Am J Public Health; 2013 Jan; 103(1):164-9. PubMed ID: 22698055
[TBL] [Abstract][Full Text] [Related]
3. Race-specific trends in HPV vaccinations and provider recommendations: persistent disparities or social progress?
Burdette AM; Webb NS; Hill TD; Jokinen-Gordon H
Public Health; 2017 Jan; 142():167-176. PubMed ID: 27592005
[TBL] [Abstract][Full Text] [Related]
4. Human papillomavirus vaccine series completion in boys before and after recommendation for routine immunization.
Ackerson B; Hechter R; Sidell M; Sy LS; Slezak J; Chao C; Patel N; Tseng HF; Jacobsen S
Vaccine; 2017 Feb; 35(6):897-902. PubMed ID: 28094077
[TBL] [Abstract][Full Text] [Related]
5. Association of Provider Recommendation and Human Papillomavirus Vaccination Initiation among Male Adolescents Aged 13-17 Years-United States.
Lu PJ; Yankey D; Fredua B; O'Halloran AC; Williams C; Markowitz LE; Elam-Evans LD
J Pediatr; 2019 Mar; 206():33-41.e1. PubMed ID: 30448270
[TBL] [Abstract][Full Text] [Related]
6. Early adoption of the human papillomavirus vaccine among Hispanic adolescent males in the United States.
Reiter PL; Brewer NT; Gilkey MB; Katz ML; Paskett ED; Smith JS
Cancer; 2014 Oct; 120(20):3200-7. PubMed ID: 24948439
[TBL] [Abstract][Full Text] [Related]
7. Area-based socioeconomic factors and Human Papillomavirus (HPV) vaccination among teen boys in the United States.
Henry KA; Swiecki-Sikora AL; Stroup AM; Warner EL; Kepka D
BMC Public Health; 2017 Jul; 18(1):19. PubMed ID: 28709420
[TBL] [Abstract][Full Text] [Related]
8. Parental intent to initiate and complete the human papillomavirus vaccine series in the USA: a nationwide, cross-sectional survey.
Sonawane K; Zhu Y; Montealegre JR; Lairson DR; Bauer C; McGee LU; Giuliano AR; Deshmukh AA
Lancet Public Health; 2020 Sep; 5(9):e484-e492. PubMed ID: 32707126
[TBL] [Abstract][Full Text] [Related]
9. Variations in reason for intention not to vaccinate across time, region, and by race/ethnicity, NIS-Teen (2008-2016).
Hirth JM; Fuchs EL; Chang M; Fernandez ME; Berenson AB
Vaccine; 2019 Jan; 37(4):595-601. PubMed ID: 30580838
[TBL] [Abstract][Full Text] [Related]
10. Disparities in Provider Recommendation of Human Papillomavirus Vaccination for U.S. Adolescents.
Mohammed KA; Geneus CJ; Osazuwa-Peters N; Adjei Boakye E; Tobo BB; Burroughs TE
J Adolesc Health; 2016 Nov; 59(5):592-598. PubMed ID: 27506278
[TBL] [Abstract][Full Text] [Related]
11. Why are U.S. girls getting meningococcal but not human papilloma virus vaccines? Comparison of factors associated with human papilloma virus and meningococcal vaccination among adolescent girls 2008 to 2012.
Perkins RB; Lin M; Silliman RA; Clark JA; Hanchate A
Womens Health Issues; 2015; 25(2):97-104. PubMed ID: 25747517
[TBL] [Abstract][Full Text] [Related]
12. Characteristics of Adolescents Lacking Provider-Recommended Human Papillomavirus Vaccination.
Krakow M; Beavis A; Cosides O; Rositch AF
J Adolesc Health; 2017 May; 60(5):619-622. PubMed ID: 28073618
[TBL] [Abstract][Full Text] [Related]
13. Racial and Ethnic Group Knowledge, Perceptions and Behaviors about Human Papillomavirus, Human Papillomavirus Vaccination, and Cervical Cancer among Adolescent Females.
Bond SM; Cartmell KB; Lopez CM; Ford ME; Brandt HM; Gore EI; Zapka JG; Alberg AJ
J Pediatr Adolesc Gynecol; 2016 Oct; 29(5):429-435. PubMed ID: 26915922
[TBL] [Abstract][Full Text] [Related]
14. Social inequalities in adolescent human papillomavirus (HPV) vaccination: a test of fundamental cause theory.
Polonijo AN; Carpiano RM
Soc Sci Med; 2013 Apr; 82():115-25. PubMed ID: 23337830
[TBL] [Abstract][Full Text] [Related]
15. Provider-verified HPV vaccine coverage among a national sample of Hispanic adolescent females.
Reiter PL; Gupta K; Brewer NT; Gilkey MB; Katz ML; Paskett ED; Smith JS
Cancer Epidemiol Biomarkers Prev; 2014 May; 23(5):742-54. PubMed ID: 24633142
[TBL] [Abstract][Full Text] [Related]
16. Trends in Adolescent Human Papillomavirus Vaccination and Parental Hesitancy in the United States.
White JL; Grabowski MK; Rositch AF; Gravitt PE; Quinn TC; Tobian AAR; Patel EU
J Infect Dis; 2023 Aug; 228(5):615-626. PubMed ID: 36869689
[TBL] [Abstract][Full Text] [Related]
17. Human papillomavirus (HPV) vaccine initiation in minority Americans.
De P; Budhwani H
Public Health; 2017 Mar; 144():86-91. PubMed ID: 28274389
[TBL] [Abstract][Full Text] [Related]
18. The prevalence of human papillomavirus vaccination among racial and ethnic minority adolescents during the COVID-19 pandemic.
Ejezie CL; Savas LS; Durand C; Shegog R; Cuccaro P
JNCI Cancer Spectr; 2023 Aug; 7(5):. PubMed ID: 37651597
[TBL] [Abstract][Full Text] [Related]
19. Approaching a decade since HPV vaccine licensure: Racial and gender disparities in knowledge and awareness of HPV and HPV vaccine.
Adjei Boakye E; Tobo BB; Rojek RP; Mohammed KA; Geneus CJ; Osazuwa-Peters N
Hum Vaccin Immunother; 2017 Nov; 13(11):2713-2722. PubMed ID: 28853980
[TBL] [Abstract][Full Text] [Related]
20. Race, ethnicity, and income factors impacting human papillomavirus vaccination rates.
Jeudin P; Liveright E; Del Carmen MG; Perkins RB
Clin Ther; 2014 Jan; 36(1):24-37. PubMed ID: 24417783
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
